|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2004-8-30
|
|
pubmed:abstractText |
Adjuvant chemotherapy is not indicated in lymph node-negative colorectal adenocarcinoma (CRC), even though some cases will present recurrent disease. It is important to identify a subgroup of patients with the highest risk of relapse because of the potential benefit of adjuvant chemotherapy. The objective of this study is to define the prognostic factors and describe a method for the selection of this subgroup.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0368-2811
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
323-8
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15333684-Adenocarcinoma,
pubmed-meshheading:15333684-Adult,
pubmed-meshheading:15333684-Aged,
pubmed-meshheading:15333684-Chemotherapy, Adjuvant,
pubmed-meshheading:15333684-Cohort Studies,
pubmed-meshheading:15333684-Colorectal Neoplasms,
pubmed-meshheading:15333684-Female,
pubmed-meshheading:15333684-Humans,
pubmed-meshheading:15333684-Lymphatic Metastasis,
pubmed-meshheading:15333684-Male,
pubmed-meshheading:15333684-Middle Aged,
pubmed-meshheading:15333684-Neoplasm Recurrence, Local,
pubmed-meshheading:15333684-Prognosis,
pubmed-meshheading:15333684-Proportional Hazards Models,
pubmed-meshheading:15333684-Retrospective Studies,
pubmed-meshheading:15333684-Time Factors
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Identification of patients with high-risk lymph node-negative colorectal cancer and potential benefit from adjuvant chemotherapy.
|
|
pubmed:affiliation |
Gastroenterology Department, Surgery Division, Instituto Nacional de Cancerología, México DF, México. lonate@prodigy.net.mx
|
|
pubmed:publicationType |
Journal Article
|
